Elexacaftor-tezacaftor-ivacaftor for individuals with residual CFTR activity: an open-label, nonrandomized clinical trial
- DOI
- 10.1093/annalsats/aaoag136
- Published
- 2026-06-10
- Container
- Annals of the American Thoracic Society
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/annalsats/aaoag136,
title = {Elexacaftor-tezacaftor-ivacaftor for individuals with residual CFTR activity: an open-label, nonrandomized clinical trial},
author = {Rachel W Linnemann and George M Solomon and Adrianna L Westbrook and Rachel Rich and Ashleigh Streby and Eric Hunter and Andras Rab and Shasha Bai and Carmel M McNicholas and Jeong S Hong and Candela Manfredi and William R Hunt and Arlene A Stecenko and Cristina Barillà and Shingo Suzuki and Brian R Davis and Eric J Sorscher},
year = {2026},
journal = {Annals of the American Thoracic Society},
doi = {10.1093/annalsats/aaoag136},
url = {https://doi.org/10.1093/annalsats/aaoag136}
}RIS
TY - JOUR TI - Elexacaftor-tezacaftor-ivacaftor for individuals with residual CFTR activity: an open-label, nonrandomized clinical trial AU - Rachel W Linnemann AU - George M Solomon AU - Adrianna L Westbrook AU - Rachel Rich AU - Ashleigh Streby AU - Eric Hunter AU - Andras Rab AU - Shasha Bai AU - Carmel M McNicholas AU - Jeong S Hong AU - Candela Manfredi AU - William R Hunt AU - Arlene A Stecenko AU - Cristina Barillà AU - Shingo Suzuki AU - Brian R Davis AU - Eric J Sorscher PY - 2026 JO - Annals of the American Thoracic Society DO - 10.1093/annalsats/aaoag136 UR - https://doi.org/10.1093/annalsats/aaoag136 ER -
APA
Linnemann, R. W., Solomon, G. M., Westbrook, A. L., Rich, R., Streby, A., Hunter, E., Rab, A., Bai, S., McNicholas, C. M., Hong, J. S., Manfredi, C., Hunt, W. R., Stecenko, A. A., Barillà, C., Suzuki, S., Davis, B. R., & Sorscher, E. J. (2026). Elexacaftor-tezacaftor-ivacaftor for individuals with residual CFTR activity: an open-label, nonrandomized clinical trial. Annals of the American Thoracic Society. https://doi.org/10.1093/annalsats/aaoag136
Source records
- crossref · retrieved 2026-09-25T09:29:55.764Z